Use of this site and material contained on its pages is for EDUCATIONAL USE ONLY.
 
Ceptic Online - View Patient Profiles

Julien, Anthony
MRN: 424697 Room: ED4 DOB: 12/01/1959 Age: 67 Gender: Male Allergies: Levofloxacin (hives), lisinopril (cough)
 Admit Notes
 Clinical Notes
 Vitals
 Labs, Cultures, Imaging
 Clinical Calculators
 MAR
 Current Orders
 Home Med List
 Med Reconciliation
 Discharge Planning
Setting Emergency Department
Scenario Please see clinical note. As a member of the patient’s care team, please address pharmacotherapy recommendations as well as other disease states to optimize this patient’s care in the hospital.
Admission note taken on 02/01/26
CC “I have a fever, I cannot keep food down or urinate.”
HPI Mr. Julien is a 67-year-old male who is presenting from home after being sent to the Emergency Department by his oncology case manager after contacting them for a new fever of 101.4°F (38.6°C) and inability to urinate in the past 24 hours. The patient recently started chemotherapy seven days ago for his newly diagnosed diffuse large B-cell lymphoma (DLBCL). He completed his last dose of a five-dose regimen of prednisone two nights ago. He mentions experiencing intractable nausea and vomiting with increased diarrhea frequency over the past few days. Mr. Julien endorses consistently taking his metoclopramide but has been having difficulty eating and sometimes vomits up his medications. The patient states he had not picked up his ondansetron ODT prescription yet. His significant other also mentions that the patient has been having difficulty sleeping and his blood glucose has been elevated for the past few days.
PMH
  • Diffuse Large B-Cell Lymphoma – diagnosed last month
    • Started treatment with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP)
      • Premedications: palonosetron 0.25 mg IV x1, fosaprepitant 150 mg IV x1, dexamethasone 12 mg IV x1
      • Day 1 (12/1): rituximab 800 mg (375 mg/m2) IV x1, cyclophosphamide 1650 mg (750 mg/m2) IV x1, doxorubicin 110 mg (50 mg/m2) IV x1, and vincristine 2 mg (1.4 mg/m2, max 2 mg) IV x1
      • Days 1-5 (12/1-12/5): prednisone 100 mg PO daily
      • Given every 3 weeks (x 6 cycles)
  • Depression – diagnosed last month
  • Hyperlipidemia – diagnosed last month
  • Hypertension – diagnosed 9 years ago
  • Chronic Kidney Disease Stage 3 – diagnosed 10 years ago
  • Type II Diabetes Mellitus – diagnosed 14 years ago
Social
History
  • Tobacco: none
  • Alcohol: drinks 2 to 3 occasionally (beer)
  • Recreational/Illicit drug use: none
  • Occupation: Librarian (retired)
Family
History
  • Mother (living) – Hypertension, Chronic Kidney Disease, Coronary Artery Disease
  • Father (living) – Type II Diabetes Mellitus, Ischemic Stroke
Vaccine
History
  • all childhood vaccines through age 18
  • Tdap: 8 years ago
  • COVID-19: doses up to date per CDC guideliness
  • Pneumococcal: doses up to date per CDC guidelines
  • Influenza (inactivated): last season
Surgical
History
  • Port placement (last month)
  • Appendectomy (17 years ago)
Physical Exam ROS
  • Constitutional: Well-developed, well-nourished male. Follows commands. Fever, chills, and fatigue
  • HEENT: No vision changes, ear pain, nasal symptoms, or sore throat
  • Respiratory: No dyspnea with exertion; no cough
  • CV: No palpitations, orthopnea, paroxysmal nocturnal dyspnea, or peripheral edema
  • GI: Nausea, vomiting, and diarrhea
  • GU: Unable to urinate in 24 hours
  • MSK: No recent injury or immobilization
  • Skin: No new rashes or skin lesions
  • Neurological: Noncontributory
  • Psychiatric: Not evaluated
PE
  • General: Elderly male, lying in bed with no acute distress
  • Head: Two small white lesions inside the mouth on left cheek, mucous membranes show inflammation
  • Eyes: Pupils equal and responsive to light
  • Neck: Supple, symmetrical
  • Neuro: Unremarkable
  • Lungs: Decreased breath sounds bilaterally, crackles, and rales
  • CV: Regular rhythm, tachycardic, no murmur or gallop
  • Abdomen: Nondistended, nontender. No rebound/guarding. No hepatosplenomegaly.
  • Skin: Dry, no external skin lesions, cuts, or bruises; Port site noted to be red and tender
  • Extremities: Pulses present in all extremities, no edema, normal range of motion
Clinical Laboratory Report
 
Test Name 02/01/2601/25/26 Range
Sodium (Na+) 140135 136-145 mEq/L
Potassium (K+) 5.44.4 3.5-5 mEq/L
Chloride (Cl-) 10695 98-106 mEq/L
Bicarbonate (HCO3-) 2223 23-28 mEq/L
Urea nitrogen (BUN) 319 8-20 mg/dL
Creatinine 3.31.4 0.5-1.3 mg/dL
Glucose 24993 70-115 mg/dL
Hemoglobin A1c 6.7 5.3-7.5 %
Calcium,Total 6.78.0 8.6-10.2 mg/dL
Phosphate 5.62.4 3-4.5 mg/dL
Magnesium 2.31.9 1.6-2.6 mEq/L
Protein, total 5.45.5 5.5-9 g/dL
Albumin 3.03.7 3.5-5.5 g/dL
Aminotransferase,aspartate (AST) 2424 10-40 units/L
Aminotransferase,alanine (ALT) 3940 10-40 units/L
Lactic dehydrogenase (LDH) 650900 80-225 units/L
Alkaline phosphatase 5958 30-120 units/L
Bilirubin, Total 0.60.4 0.3-1 mg/dL
Leukocytes (WBC) 0.66.7 4.5-11 x103/mcL
Red blood cells (RBC), Male4.14.23.8-5.1 x108/mcL
Hemoglobin, Male11.213.114-18 g/dL
Hematocrit, Male404342-50 %
Mean corpuscular hemoglobin (MCH) 3131 27-33 picogram
Mean corpuscular volume (MCV) 8079 76-100 mcm3
Platelets 76189 150-450 x103/mcL
International normalized ratio (INR) 1.11.0 0.8-1.2
Prothrombin time (PT) 10.510.4 9.5-11.3 sec
Partial thromboplastin time,activated (aPTT) 3130 25-35 sec

 
 
Additional Labs:


Other Labs Today 7 days ago
Uric Acid (mg/dL) 10.2 6.1
Serum alcohol (%) 0
Hepatitis B surface antigen (HBsAg) Negative
Hepatitis B surface antibody (anti-HBs) Positive
Hepatitis B core antibody (anti-HBc) Negative


Fasting Lipid Panel (7 days ago) Result
Total cholesterol (mg/dL) 154
LDL-C (mg/dL) 92
HDL (mg/dL) 40
Triglycerides (mg/dL) 112
CBC Today 7 days ago
Segmented neutrophils (%) 10 50
Band neutrophils (%) 60 16
Lymphocytes (%) 25 30
Monocytes (%) 3 2
Eosinophils (%) 2 1
Basophils (%) 0 1
Absolute Neutrophil Count (cells/mm3) 420 4,422
Cultures:
Cultures (today) Result
Blood cultures (two sets: left antecubital fossa and from port) pending
Respiratory pathogen PCR panel pending
Gastrointestinal pathogen PCR panel pending
Pneumococcal urine antigen pending
Legionella urine antigen pending
Imaging Studies:
Diagnostic Tests (today) Result
CTA thorax without contrast Bibasilar atelectasis noted in both lungs. No evidence of pulmonary embolism.
CT abdomen and pelvis without contrast pending
ECG regular rhythm, QTc within normal limits
Vital Sign 02/01/26
09:25
Height (cm) 180
Weight (kg) 96
Body Temperature (°C) 38.9
Blood Pressure (mmHg) 89 / 65
Heart Rate (bpm) 110
Respiratory Rate (bpm) 19
Oxygen Saturation (%) 89
Current Orders
 
CONC
VOL
SOLN
RATE

CONC
VOL
SOLN
RATE

USE
START DATE
STOP DATE
NOTES

 

 

USE
START DATE
STOP DATE
NOTES

 

 

USE
START DATE
STOP DATE
NOTES

 

 

CONC
VOL
SOLN

USE
START DATE
STOP DATE
NOTES

 

 

USE
START DATE
STOP DATE
NOTES

 

 

CONC
VOL
SOLN
RATE

Medication
History
  • The patient’s significant other brought the patient’s pillbox organizer to the ED.
  • The patient and significant other stated that he takes his medications as prescribed, but they are uncertain what pills he vomited up over the past several days.
  • He was using only metoclopramide for nausea and his diarrhea has worsened. He had been planning on discussing his diarrhea with his oncologist at his next appointment.
  • He was planning to pick up the ondansetron ODT prescription today.
  • Patient has not used any as needed OTC medications in the past 72 hours.

 
Home Medication List: verified by pharmacy on admit (02/01/26)
 
Patient Name: Julien, Anthony
Date of Birth: 12/01/1959
Room#: ED4
Allergies:
Immunization History:
Community Rx Info:
 
Rx Insurance:
Social History:
Additional Notes:
DRUG
STRENGTH
DF
STRENGTH
ROUTE
FREQ
PRN?
LAST
DOSE
(date/time)
ADVERSE
EFFECTS
ADHERENCE
NOTES
MED REC
ACTION
MED REC
REASON
Action Key:
C = Continue, D = Discontinue*, H = Hold*, M = Modify*
*must provide reason

                    
Medication 02/01/26
Vancomycin  500 mg  IV  Q12H *Pharmacy to dose
Rate: 100 mL/hr
Cefepime  1,000 mg  IV  Q24H
Rate: 100 mL/hr
Sodium Chloride 0.9% Solution    IV  continuous, 75 mL/hr
Insulin glargine  10 units  SC  Q24H
Senna/Docusate  8.6 mg/50 mg  PO  Q12H
Enoxaparin  40 mg  SC  Q12H
Acyclovir  400 mg  PO  Q12H
Sulfamethoxazole/Trimethoprim  800 mg/160 mg  PO  3x/week
Metoclopramide  10 mg  IV  Q6H  PRN
PRN nausea
Rate: 1 mL/min
Clinical Notes
 
                    
Medication Discharge Orders
 
Hospital Medications
Medication Instructions Comments Continue Modify Discontinue New Rx sent

 
Previous Home Medications
Medication Instructions Comments Continue Modify Discontinue New Rx sent

 
 
Discharge Planning - Medication List and Instructions
 
Patient Name:
Admission Date: Discharge Date: Service:
Principle Diagnosis on Admission:
Secondary Diagnosis:
Allergies:

 
Medications ADDED this visit:
(begin taking these)
Medications CHANGED this visit:
(modify what you were taking)
Medications STOPPED this visit:
(stop taking these)

 
Final Discharge Medication List
Medication/Route/Dosage/Frequency/Duration Comments Morning Afternoon Evening Bedtime
As Needed Medications

 
          
Medication Reconciliation - Finalized Medication List
 
Patient Name: Julien, Anthony Date of Birth: 12/01/1959 Room: ED4

 
Medication (name/strength) Dose Route Frequency Notes